Metronidazole Noridem

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole presented as an injectable solution for intravenous use. It treats a range of anaerobic bacterial infections and related conditions in adult patients.

GNH USA supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazole Noridem is an antibiotic that targets anaerobic organisms and protozoa, making it useful for several infectious disease categories. - Anaerobic bacterial infections: effective against mixed anaerobic infections, reducing bacterial load. - Bacterial vaginosis: restores normal vaginal flora by eliminating over‑growth of anaerobes. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving symptoms and preventing recurrence. - Amebic liver abscess: eliminates Entamoeba histolytica in hepatic tissue, aiding recovery. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, helping resolve colitis.

Metronidazole Noridem may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: upset stomach often occurring shortly after infusion. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache during or after treatment. - Dizziness: occasional light‑headedness. - Diarrhea: loose stools may appear. - Abdominal pain: cramping or discomfort in the abdomen.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reaction (anaphylaxis): hives, swelling, breathing difficulty. - Stevens‑Johnson syndrome: severe skin blistering and detachment. - Hepatic toxicity: elevated liver enzymes or jaundice. - Neutropenia: marked reduction in white blood cells.

Before using Metronidazole Noridem, consider the following safety measures. - Renal impairment: adjust therapy in patients with reduced kidney function. - Hepatic dysfunction: monitor liver enzymes and avoid in severe liver disease. - Alcohol consumption: advise patients to avoid alcohol due to disulfiram‑like reaction. - Pregnancy: use only if benefits outweigh potential risks; category unknown. - Pediatric use: safety and efficacy not established in children. - Store at ambient temperature: keep in original container, protect from moisture and light.

Metronidazole Noridem can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium levels, leading to toxicity. - Strong CYP450 inhibitors (e.g., cimetidine): increase metronidazole plasma concentrations. - Live vaccines: risk of infection due to immunosuppression.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced efficacy, consider alternative contraception. - Phenytoin: may lower metronidazole levels, reducing effectiveness. - Carbamazepine: may decrease metronidazole concentrations, requiring dose adjustment.